LOG IN
SIGN UP
MARKET
EVOK
EVOK
Evoke Pharma Inc
NASDAQ
1.990
+0.100
+5.30%
Opening 09:55 03/31 EDT
OPEN
1.960
PREV CLOSE
1.890
HIGH
1.990
LOW
1.901
VOLUME
2.98K
TURNOVER
5.69K
52 WEEK HIGH
16.80
52 WEEK LOW
1.372
MARKET CAP
6.65M
P/E (TTM)
-0.7315
1D
5D
1M
3M
1Y
5Y
Evoke Pharma & EVERSANA Announce Compelling Real-World Data On The Impact Of GIMOTI In Reducing The Utilization Of Healthcare Resources To Be Presented At The Academy Of Managed Care Pharmacy 2023
Benzinga · 03/23 12:34
Evoke Pharma's Return On Capital Employed Insights
Benzinga · 03/22 14:45
Evoke Pharma GAAP EPS of $0.54 beats by $1.07, revenue of $0.79M misses by $0.1M
Seeking Alpha · 03/21 20:24
BRIEF-Evoke Pharma Reports Fourth Quarter Financial Results
Reuters · 03/21 20:10
Evoke Pharma Q4 EPS $(0.54) Misses $(0.53) Estimate
Benzinga · 03/21 20:09
Evoke Pharma's Q4 Loss per Share Narrows, Revenue Gains
Evoke Pharma's Q4 Loss per Share Narrows, Revenue Gains
MT Newswires · 03/21 16:42
-- Earnings Flash (EVOK) EVOKE PHARMA Posts Q4 Revenue $796,000
-- Earnings Flash (EVOK) EVOKE PHARMA Posts Q4 Revenue $796,000
MT Newswires · 03/21 16:24
Earnings Scheduled For March 21, 2023
Benzinga · 03/21 10:46
About EVOK
Evoke Pharma, Inc. (Evoke) is a specialty pharmaceutical company that owns and operates in the development and commercialization of pharmaceutical products. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. Evoke is developing its product Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Gimoti, is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide offering systemic delivery by nasal spray administration.
Webull offers kinds of Evoke Pharma Inc stock information, including NASDAQ:EVOK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVOK stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading EVOK stock methods without spending real money on the virtual paper trading platform.